24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Degenerative diseases
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
06:30
IAI nears $900 million India deal for six aerial refueling aircraft
21:53
Google, Amazon and Intel stumble as investors begin to question the price of the AI boom
12:53
Every student deserves a personal tutor, inside the classroom, too.
09:51
AI companies say their models are the best. Here's how to tell if that's true
More stories
Buzz
Most popular
Daily
Weekly
1
"A gorgeous situation": ServiceNow's CEO celebrates a shrinking workforce
2
Cyber startup Cyera eyes $20 billion valuation in new funding talks
3
Stealth Israeli cyber startup valued at over $1.5 billion recruits former 8200 chief
4
Intel’s $600 million question: How the Kiryat Gat explosion hit its forecast
5
BrainPOP's mind-blowing deal: Israeli founder nets $875 million from deal with Lego
More news
Degenerative diseases
1 stories about Degenerative diseases
Check Point Founder Invests in Clinical Stage Company Regenera Pharma
02.01.18
|
Dror Reich
The company intends to use the funding for a phase 3 clinical trial of its drug for sudden vision loss